Insider · CIK 0001920511
Cheryl Yvonne Grenas
Files at NUTX (Nutex Health, Inc.). First filing -, latest -.
In brief
Cheryl Yvonne Grenas files SEC Form 4 as director at NUTX (Nutex Health, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Cheryl Yvonne Grenas has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | NUTX Nutex Health, Inc. | MOption exercise Common Stock | +603 | $0.00 | $0 | 670 | Aug 3, 2026 |
| Apr 23, 2026 | NUTX Nutex Health, Inc. | AGrant or award Restricted Stock Units (RSUs)derivative | +823 | $0.00 | $0 | 1,426 | Apr 24, 2026 |
| Jul 14, 2025 | NUTX Nutex Health, Inc. | AGrant or award Restricted Stock Units (RSUs)derivative | +603 | $0.00 | $0 | 603 | Feb 9, 2026 |
Questions about Cheryl Yvonne Grenas
Answered from the filings on this page, as of the latest one.
Is Cheryl Yvonne Grenas buying or selling?
Cheryl Yvonne Grenas has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Cheryl Yvonne Grenas's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Cheryl Yvonne Grenas has 0.
Where does Cheryl Yvonne Grenas file Form 4?
Cheryl Yvonne Grenas has filed Form 4 at NUTX (Nutex Health, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.